Skip to main content
. Author manuscript; available in PMC: 2020 Oct 4.
Published in final edited form as: ChemMedChem. 2019 Sep 23;14(19):1735–1741. doi: 10.1002/cmdc.201900217

Table 1.

a Minimum inhibitory concentrations (MICs) of 2 - 6 in M. tuberculosis H37Rv and cytotoxicity evaluation in HepG2 cells in presence of glucose (Glu) and galactose (Gal). Activity of compounds 2 - 6 against intracellular M. tuberculosis H37Rv.

Minimum inhibitory concentrations (μM) Intracellular assay (μM)
Compound H37Rv MIC90[b] HepG2 (Glu) IC50[c] HepG2 (Gal) IC50[c] Ratio (Glu/Gal) RAW 264.7 IC50[d] Intracellular Mtb IC90[e]
2 >20 (0) 79 (0.6) 34 (1.1) 2.3 39 (4.6) >33 (4.8)
3 >20 (0) >100 (0) >100 (0) N/A >100 (0) >100 (0)
4 >20 (0) 69 (1.2) 41 (0.7) 1.7 8 (1.1) >3.7 (0)
5 13 (2.5) 36 (0) 29 (0.5) 1.2 29 (0.5) 9.3 (0.8)
6 >20 (0) >100 (0) 22 (1.9) >4.5 2.6 (0.6) >3.7 (1.1)
Rifampicin 0.1 (0.6) >100 (0) NA NA NA NA
[a]

The experiments were conducted in triplicate and error values are reported in brackets as Standard Deviation (STDEV) values.

[b]

MIC90 was defined as the concentration required to inhibit growth of M. tuberculosis in liquid medium by 90% after 5 days.

[c]

IC50 is the concentration required to reduce viability of HepG2 cells (cultured with either glucose or galactose) by 50% after 2 days.

[d]

IC50 is the concentration required to reduce viability of RAW 264.7 cells by 50% after 3 days.

[e]

IC90 is the concentration required to inhibit the growth of M. tuberculosis in liquid medium by 90% after 3 days. NA = not available.